- Home
- PVH vs HALO Comparison
PVH vs HALO Comparison
Compare PVH & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVH
- HALO
- Stock Information
- Founded
- PVH 1881
- HALO 1998
- Country
- PVH United States
- HALO United States
- Employees
- PVH N/A
- HALO N/A
- Industry
- PVH Apparel
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PVH Consumer Discretionary
- HALO Health Care
- Exchange
- PVH Nasdaq
- HALO Nasdaq
- Market Cap
- PVH 5.7B
- HALO 6.4B
- IPO Year
- PVH N/A
- HALO N/A
- Fundamental
- Price
- PVH $102.13
- HALO $45.65
- Analyst Decision
- PVH Buy
- HALO Buy
- Analyst Count
- PVH 17
- HALO 9
- Target Price
- PVH $126.59
- HALO $61.11
- AVG Volume (30 Days)
- PVH 651.4K
- HALO 1.7M
- Earning Date
- PVH 11-27-2024
- HALO 10-31-2024
- Dividend Yield
- PVH 0.15%
- HALO N/A
- EPS Growth
- PVH 341.62
- HALO 61.71
- EPS
- PVH 12.62
- HALO 3.02
- Revenue
- PVH $8,879,000,000.00
- HALO $947,355,000.00
- Revenue This Year
- PVH N/A
- HALO $23.36
- Revenue Next Year
- PVH $1.92
- HALO $15.15
- P/E Ratio
- PVH $8.09
- HALO $15.10
- Revenue Growth
- PVH N/A
- HALO 21.35
- 52 Week Low
- PVH $83.71
- HALO $33.15
- 52 Week High
- PVH $141.15
- HALO $65.53
- Technical
- Relative Strength Index (RSI)
- PVH 56.11
- HALO 30.20
- Support Level
- PVH $100.97
- HALO $50.01
- Resistance Level
- PVH $104.94
- HALO $62.13
- Average True Range (ATR)
- PVH 2.77
- HALO 2.60
- MACD
- PVH 0.31
- HALO -0.50
- Stochastic Oscillator
- PVH 67.89
- HALO 0.15
About PVH PVH Corp.
PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites and about 1,500 stores, licenses its brands to third parties, and distributes its merchandise through department stores and other wholesale accounts. The firm traces its history to 1881 and is based in New York City.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.